What does CUSIP 92243G108 represent in this 13F holders report?

CUSIP 92243G108 is the security identifier for PCVX - Vaxcyte, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held PCVX - Vaxcyte, Inc. - COMMON STOCK in Q1 2023?

186 institutional investors reported PCVX - Vaxcyte, Inc. - COMMON STOCK for Q1 2023. Use the holders table for investor-level position and value details.

Vaxcyte, Inc. - COMMON STOCK (PCVX)

CUSIP: 92243G108

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / COMMON STOCK
Shares outstanding: 144,307,555
Total 13F shares: 84,121,058
Share change: +4,578,082
Total reported value: $3,152,798,116
Put/Call ratio: 59%
Price per share: $37.48
Number of holders: 186
Value change: +$159,886,756
Number of buys: 92
Number of sells: 92

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 92243G108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PCVX - Vaxcyte, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7%	10,169,282	$487,617,048	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	4.6%	6,613,666	$317,125,284	—	31 Dec 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	4.1%	5,974,139	$286,454,808	—	31 Dec 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4.1%	5,857,459	$280,865,159	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	3.5%	5,105,370	$244,802,492	—	31 Dec 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.4%	3,528,114	$169,173,067	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	2.2%	3,167,981	$151,904,689	—	31 Dec 2022	13F
Capital Research Global Investors	13F	Company	1.9%	2,806,002	$134,547,796	—	31 Dec 2022	13F
Abingworth LLP	13F	Company	1.4%	2,019,057	$96,813,783	—	31 Dec 2022	13F
Avidity Partners Management LP	13F	Company	1.1%	1,615,400	$77,458,430	—	31 Dec 2022	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	1%	1,457,300	$69,877,535	—	31 Dec 2022	13F
JENNISON ASSOCIATES LLC	13F	Company	0.99%	1,422,007	$68,185,236	—	31 Dec 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.97%	1,397,405	$67,005,570	—	31 Dec 2022	13F
BRAIDWELL LP	13F	Company	0.94%	1,362,278	$65,321,230	—	31 Dec 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.89%	1,283,126	$61,525,892	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.87%	1,251,433	$60,006,000	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.85%	1,219,491	$58,475,000	—	31 Dec 2022	13F
TPG GP A, LLC	13F	Company	0.82%	1,190,336	$57,076,611	—	31 Dec 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.81%	1,170,000	$56,101,500	—	31 Dec 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.67%	972,321	$46,622,792	—	31 Dec 2022	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.61%	877,293	$42,066,199	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.59%	851,858	$40,846,591	—	31 Dec 2022	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.58%	830,795	$39,836,620	—	31 Dec 2022	13F
GREAT POINT PARTNERS LLC	13F	Company	0.55%	800,000	$38,360,000	—	31 Dec 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.55%	795,000	$38,120,250	—	31 Dec 2022	13F
Novo Holdings A/S	13F	Company	0.5%	725,000	$34,763,750	—	31 Dec 2022	13F
Kynam Capital Management, LP	13F	Company	0.49%	703,441	$33,729,996	—	31 Dec 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.49%	700,000	$33,565,000	—	31 Dec 2022	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.48%	693,039	$33,231,220	—	31 Dec 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.46%	666,467	$31,958,000	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	0.46%	659,331	$31,614,921	—	31 Dec 2022	13F
Vivo Capital, LLC	13F	Company	0.4%	579,508	$27,787,000	—	31 Dec 2022	13F
Polar Asset Management Partners Inc.	13F	Company	0.39%	555,900	$26,655,405	—	31 Dec 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.36%	521,977	$25,029,000	—	31 Dec 2022	13F
T. Rowe Price Investment Management, Inc.	13F	Company	0.35%	511,436	$24,524,000	—	31 Dec 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.34%	488,479	$23,422,568	—	31 Dec 2022	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.34%	485,538	$23,260,474	—	31 Dec 2022	13F
Jeff Fairman	3/4/5	VP, Research	— mixed-class rows	369,054 mixed-class rows	$22,935,618	—	30 Dec 2022	3/4/5
GOLDMAN SACHS GROUP INC	13F	Company	0.28%	399,364	$19,149,503	—	31 Dec 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.27%	387,950	$18,602,203	—	31 Dec 2022	13F
Cormorant Asset Management, LP	13F	Company	0.23%	325,000	$15,584,000	—	31 Dec 2022	13F
MARSHALL WACE, LLP	13F	Company	0.22%	322,600	$15,468,671	—	31 Dec 2022	13F
Bank of New York Mellon Corp	13F	Company	0.21%	307,648	$14,751,721	—	31 Dec 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.21%	302,600	$14,509,670	—	31 Dec 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.21%	300,000	$14,385,000	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.21%	296,619	$14,222,882	—	31 Dec 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.2%	284,520	$13,643,000	—	31 Dec 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	256,376	$12,293,000	—	31 Dec 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.18%	252,932	$12,127,000	—	31 Dec 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.17%	251,186	$12,044,369	—	31 Dec 2022	13F

Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q1 2023

As of 31 Mar 2023, Vaxcyte, Inc. - COMMON STOCK (PCVX) was held by 186 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 84,121,058 shares. The largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, Carlyle Group Inc., and Medicxi Ventures Management (Jersey) Ltd. This page lists 186 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

197

Q1 2023 holders

186

Holder diff

-11

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.